Evidence level: C
上一篇的判据写「年龄解释方差超过 50% 就改用同年龄常模 z 化的余量」,这话暗示 z 化能把终点救回来。但代数学上它救不了:z 化不改变测量标准误,一丝都不改。它唯一改的,是信度系数那个数字本身。
正文
先把上一篇留下的那句话拆开看。它说的是:余量这个终点,如果年龄解释方差太大(比如 r²=0.71,来自 DR2 与年龄的相关),那这个终点其实在测年龄,不是在测「沉而不塌」,所以应该换成同年龄常模 z 化之后的余量。逻辑前半段没问题——一个被年龄吃掉七成方差的指标,确实不能直接做组间比较。问题出在「所以 z 化」这一步:它默认了 z 化能修好什么东西,而这一步没有任何代数支撑。
第一件事:SEM 是个不变量。 设一个人群里的余量总方差 VT = VB + VE(VB 是个体间真差,VE 是测量误差),信度 ICC = VB/VT,年龄占真差 VB 的比例是 r²。z 化就是把每个人的值按年龄除以本年龄段的 SD。做完之后,尺度缩了 √(1−r²) 倍,ICC 变成 (ICC−r²)/(1−r²)——难看了。但把两个数代进标准误公式 SEM = SD·√(1−ICC),会看到 SD 缩了 √(1−r²),而 √(1−ICC) 恰好涨了 1/√(1−r²),两者精确抵消,SEM 一分不变。实算三档(r² 取 0.30 / 0.50 / 0.71,ICC 取 0.75 与 0.90),SEM 比全部是 1.000000。MDC95 = 1.96√2·SEM,自然同样不变;组级最小可检测差 = 1.96·√2·SEM/√n,也不变。这不是近似,是恒等式。
第二件事:ICC 会掉,而且能掉到负数。 ICC=0.75 时,r²=0.30 落到 0.643,r²=0.50 落到 0.500,r²=0.71 直接落到 0.138——从「合格」掉进「不合格」只需一步。更狠的是临界点:按这个口径,ICCz 跌破零的条件是 r² > ICC。ICC 本来就只有 0.75,意味着年龄只要解释七成半的真差,z 化后的「信度」就是负的,这个数已经没有意义。所以「z 化后再看 ICC 是否合格」这条判据,在它最想用的高 r² 场景里必然判死——不是终点不行,是判据自己造的。
第三件事:r² 的分母被悄悄换过。 「年龄解释方差」可以指占总方差的比例,也可以指占组间真差的比例。同一个 ICC=0.75、r²=0.71 的数据,按前者算得 ICCz=0.138,按后者算得 0.465,差 0.327。前者判死、后者勉强及格,结论反向。源判据没写清分母是哪个,而这两套算法在文献里都有人用。一个判据的结论取决于一个没定义的分母,它就不是判据。
第四件事:z 化真正改的是效应量,而且是往大改。 尺度缩了 √(1−r²) 倍,标准化效应量 d 就放大 1/√(1−r²) 倍:r²=0.30 是 1.195 倍,0.50 是 1.414 倍,0.71 是 1.857 倍。表面看这是好事——效应变大、样本可以省。但这是纯粹的记账错觉:SD 之所以变小,是因为年龄带来的个体差被除掉了,而那部分差里既有「年龄污染」,也有真实的个体差异。z 化不区分这两者,一律除掉。所以放大后的 d 对应的不是「效应更强」,而是「人群被人为削窄了」。ICC 依赖人群异质性,削窄人群必然同时压低 ICC——同一件事的两个面孔。
第五件事:z 化不等于年龄配对。 配对抽样(1:1 配到同年龄)消掉的只是「年龄与分组的共线」,同龄人之间的个体差原样保留,SD 也只缩了年龄独有那一份。z 化则把整个年龄段内的全部个体差一起除掉。两者在「控年龄」这一层目标相同,在对「真个体差」的处理上完全不同:配对保它,z 化削它。所以「配对后组间差与 z 化后组间差差多少」本身就是一个诊断量——若差超过一个 MDC95,说明年龄与真个体差高度共线,任何 z 化都同时削掉了研究对象。
那这条线该怎么落地。 原文给的实验设计(≥120 名成人、年龄跨度 ≥40 岁、隔 3–7 天 × 3 次 SVC-FOT,并算原始与 z 化两套 ICC/SEM/MDC95/组级门槛,另设年龄 1:1 配对对照)是合适的,问题只在判据的写法。按上面的代数,判据应当改成:若 z 化后 SEM 与 MDC95 变化 <5%(这是恒等式保证的必然结果)而 ICC 下降 >0.10,则证实「z 化治偏倚不治噪声」,删去 z 化条款,改为按年龄配对设计、报原始尺度 ICC;只有当 z 化后 SEM 真的降了 >15% 时,才说明年龄与测量误差本身耦合(即误差方差随年龄变,非同方差),z 化确实改善精度,原判据可留;若配对与 z 化的组间差相差超过 1 个 MDC95,则偏倚量级已足以翻转结论,一切组间比较须配对后重做。
要说明的是,上面这些代数都只在「测量学」这一层成立,它们不涉及任何易学命题的真伪。本节讨论的终点(呼气末容积到 DR2 的余量)在现有对应网络里只挂到「金—肺」这条边,而这条边的现代证据栏至今空着。所以本文的所有结论只能读到这个程度:即使将来这条边被证实,「z 化能救终点」这个推论也是错的;反过来,如果这条边本身就不成立,谈终点精度更是空中楼阁。这是本文标 C 的理由。
证据与局限
已验证: 代数部分是恒等式,不依赖样本。SEM = SD·√(1−ICC) 在 z 化下严格不变(两种 r² 口径下实算 SEM 比均为 1.000000),ICCz = (ICC−r²)/(1−r²) 在 r²=0.30/0.50/0.71 三档下给出 0.643/0.500/0.138,要维持 ICCz≥0.75 需原始 ICC 达 0.825/0.875/0.928。ICC 本身依赖人群异质性、跨样本不可直接外推(PMID 29707825);异方差未校正会系统性高估 ICC(PMID 30208858)。
部分验证: 「残差化/z 化不是万灵药」在别的领域已有实测支持——HRV 生物标志物研究中六种年龄归一化策略(含残差化、年龄段 z 分、多项式交互、简单除法)在严格验证下均无临床意义改善,部分反而更差;残差化处理共线性会引入系数与标准误偏倚(PMID 23017962)。肺功能侧,成人参考值普遍以身高为首要预测因子、年龄贡献在 >65 岁人群中被报为可忽略(PMID 16204589、PMID 29470844),而 FOT 阻抗的日间变异本身就有 5%–15%(PMID 23598954)——这说明「年龄这一项该不该扣」在不同人群里答案不同,不能一刀切。
待验证: ① 余量(EELV−DR2)在 SVC-FOT 上的 ICC 与 SEM 从未被本领域实测报过,全部数值来自恒等式推演与跨领域对照;② 「年龄与测量误差耦合(异方差)」这一支是否存在,本篇无法判断——若存在,恒等式的前提(误差方差与年龄无关)就不成立,SEM 会真的变化;③ 年龄配对与 z 化在同一预期差下的检验力差异,需要实做才能给出量级。此外,本篇所依附的「金—肺」边在 L1 网络中仍为 open、现代证据待补,属结构性缺口。
相关阅读
证据等级: C
参考文献: PMID 30208858, PMID 23017962, PMID 16204589, PMID 29470844, PMID 23598954, PMID 29707825, PMID 34232924, PMID 24338600L1 网络状态:
| E-004 | 金 | 主 | 肺 | 《素问·阴阳应象大论》 | 待补 | L1 | open |(现代证据栏为「待补」,层级仅 L1 同构,状态 open;本文所讨论的呼吸力学终点在该网络中无独立边,故证据等级按硬规则封顶为 C)
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
What Age Norms Z-Score Actually Changes: Zero Contribution to Detecting Small Differences, Only Making ICC Look Worse
Evidence level: C
The criterion in the previous post stated: “If age-explained variance exceeds 50%, switch to the margin after z-scoring by age.” This phrasing implies z-scoring rescues the endpoint. Algebraically, it does not: z-scoring does not change the measurement standard error (SEM) by even a fraction. It only alters the reliability coefficient number itself.
Main Body
Let’s unpack the previous statement. It claims: if age-explained variance is too large (e.g., r² = 0.71, from the correlation between DR2 and age), then this endpoint is actually measuring age rather than “sinking without sinking,” so we should switch to the margin after z-scoring by age. The first part of the logic holds—a metric with 70% of its variance eaten by age cannot be directly compared across groups. The problem lies in the “therefore z-score” step: it assumes z-scoring fixes something, yet this step lacks algebraic support.
First point: SEM is an invariant. Consider the total variance VT = VB + VE in a population (VB is true between-subject difference, VE is measurement error). The reliability ICC = VB/VT, and the proportion of true difference VB explained by age is r². Z-scoring divides each person’s value by the SD of their age group. After this, the scale shrinks by √(1−r²), and ICC becomes (ICC−r²)/(1−r²)—which looks worse. However, plugging these into the SEM formula SEM = SD·√(1−ICC) reveals that SD shrinks by √(1−r²), while √(1−ICC) increases exactly by 1/√(1−r²), canceling each other precisely. SEM remains unchanged. Calculating three tiers (r² = 0.30 / 0.50 / 0.71, ICC = 0.75 and 0.90), SEM ratios are all exactly 1.000000. MDC95 = 1.96√2·SEM, naturally unchanged; the group-level minimum detectable difference = 1.96·√2·SEM/√n, also unchanged. This is not an approximation—it is an identity.
Second point: ICC will drop, and can drop into negative numbers. When ICC = 0.75, r² = 0.30 falls to 0.643, r² = 0.50 falls to 0.500, and r² = 0.71 drops directly to 0.138—from “qualified” to “unqualified” in one step. More critically, the threshold: under this definition, ICCz drops below zero when r² > ICC. Since ICC itself is only 0.75, this means age must explain more than three-quarters of true difference for z-scored “reliability” to become negative—a number that is meaningless. Thus, the criterion “check if ICCz is qualified after z-scoring” inevitably fails in high r² scenarios—not because the endpoint is bad, but because the criterion itself is constructed to fail.
Third point: the denominator of r² is silently swapped. “Age-explained variance” can refer either to the proportion of total variance or to the proportion of true between-subject difference. For the same ICC = 0.75 and r² = 0.71, calculating ICCz using the former yields 0.138, while using the latter gives 0.465—a difference of 0.327. The former fails qualification, the latter barely passes, reversing the conclusion. The source criterion does not specify which denominator is used, yet both algorithms appear in literature. A criterion’s conclusion depending on an undefined denominator renders it not a criterion at all.
Fourth point: z-scoring actually changes effect size, making it larger. The scale shrinks by √(1−r²), so the standardized effect size d amplifies by 1/√(1−r²): r² = 0.30 gives 1.195×, 0.50 gives 1.414×, and 0.71 gives 1.857×. Superficially this seems beneficial—effect sizes grow, samples can shrink. But this is pure accounting illusion: SD shrinks because age-induced individual differences are divided out, and that part of difference contains both “age contamination” and true individual variation. Z-scoring does not distinguish these two; it removes both. Thus, the amplified d corresponds not to “stronger effects” but to “the population being artificially narrowed.” ICC depends on population heterogeneity; narrowing the population inevitably suppresses ICC—the two faces of the same coin.
Fifth point: z-scoring is not age pairing. Paired sampling (1:1 matching to same age) removes only “age and group collinearity,” preserving individual differences among same-age people, so SD shrinks only by the age-specific portion. Z-scoring removes all individual differences within an entire age band. Both aim to control age, but differ fundamentally in handling “true individual differences”: pairing preserves them, z-scoring shrinks them. Thus, “how much the between-group difference after pairing differs from that after z-scoring” itself becomes a diagnostic metric—if this difference exceeds one MDC95, it indicates high collinearity between age and true individual differences, meaning any z-scoring simultaneously removes the study subjects.
How to implement this line. The experimental design given (≥120 adults, age span ≥40 years, SVC-FOT repeated 3 times over 3–7 days, calculating both raw and z-scored ICC/SEM/MDC95/group thresholds, plus age 1:1 pairing control) is appropriate; the issue lies only in the criterion wording. Based on the algebra above, the criterion should be revised: if SEM and MDC95 change <5% after z-scoring (an inevitable result of the identity) while ICC drops >0.10, this confirms “z-scoring corrects bias but not noise,” delete the z-scoring clause, switch to age-paired design, and report raw-scale ICC; only if SEM truly drops >15% after z-scoring (indicating age and measurement error are coupled, i.e., error variance varies with age, not homoscedastic) does z-scoring genuinely improve precision, so keep the original criterion; if the between-group difference after pairing and z-scoring exceeds 1 MDC95, then bias magnitude is sufficient to flip conclusions, so all between-group comparisons must be re-done after pairing.
It should be noted that the algebra above holds only at the “metrology” level and involves no Yijing Studies propositions of truth or falsity. The endpoint discussed here (residual from end-expiratory lung volume to DR2) in the current correspondence network connects only to the “gold-lung” edge, whose modern evidence column remains empty. Therefore, all conclusions in this article can only reach this extent: even if this edge is confirmed in the future, the inference “z-scoring rescues the endpoint” is wrong; conversely, if this edge itself does not hold, discussing endpoint precision is building on air. This is the reason for evidence level C.
Evidence and Limitations
Verified: The algebraic parts are identities, independent of sample size. SEM = SD·√(1−ICC) remains strictly unchanged under z-scoring (both r² definitions yield SEM ratios of exactly 1.000000). ICCz = (ICC−r²)/(1−r²) gives 0.643/0.500/0.138 for r² = 0.30/0.50/0.71 respectively; maintaining ICCz ≥ 0.75 requires raw ICC to reach 0.825/0.875/0.928. ICC itself depends on population heterogeneity and cannot be directly extrapolated across samples (PMID 29707825); uncorrected heteroscedasticity systematically overestimates ICC (PMID 30208858).
Partially verified: “Residualization/z-scoring is not a panacea” has empirical support in other fields—HRV biomarker studies found six age-normalization strategies (including residualization, age-band z-scores, polynomial interaction, simple division) showed no clinically meaningful improvement under strict validation, with some performing worse; residualization introduces coefficient and standard error bias due to collinearity (PMID 23017962). In lung function, adult reference values universally use height as the primary predictor, with age contribution reported as negligible in populations >65 years (PMID 16204589, PMID 29470844), while FOT impedance’s within-day variability itself ranges 5%–15% (PMID 23598954)—indicating whether “age should be subtracted” varies by population, precluding a one-size-fits-all approach.
To be verified: ① ICC and SEM for the margin (EELV−DR2) on SVC-FOT have never been empirically reported in this field; all values derive from identity-based deduction and cross-domain comparison; ② whether the branch “age and measurement error coupling (heteroscedasticity)” exists cannot be judged here—if it does, the identity’s premise (error variance independent of age) fails, and SEM would truly change; ③ power differences between age pairing and z-scoring under the same expected difference require actual implementation to quantify. Additionally, the “gold-lung” edge this article relies on remains open in the L1 network, with modern evidence pending, constituting a structural gap.
Further Reading
- “Is the new endpoint ‘margin’ qualified enough: MDC95 level mixing, and age as an unavoidable confounder”
- “Pre-screening of variance components in healthy populations: ceiling effects rendering metrics unusable”
- “Variance share of dantian parameters versus within-group reliability”
- “Biological frequency code (research pool)”
Evidence level: C
References: PMID 30208858, PMID 23017962, PMID 16204589, PMID 29470844, PMID 23598954, PMID 29707825, PMID 34232924, PMID 24338600L1 network status:
| E-004 | 金 | 主 | 肺 | 《素问·阴阳应象大论》 | 待补 | L1 | open |(modern evidence column marked “pending,” level only L1 isomorphic, status open; the respiratory mechanics endpoint discussed here has no independent edge in this network, so evidence level capped at C by hard rules)
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply